Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 12, 258 (2006)
Published online: 28 February 2006 | doi:10.1038/nm0306-258b
One year after launch, drug safety board is dubbed a failure
Meredith Wadman1
- Washington, DC
A new drug safety board at the US Food and Drug Administration (FDA) is failing in its declared goal of increasing openness and transparency at the agency, members of an FDA advisory committee said in February.Exactly a year ago, the FDA announced with much fanfare the launch of a new panel aimed at improving the agency's management of drug safety issues—including releasing early warnings when safety issues begin to emerge.
To read this story in full you will need to login or make a payment (see right).
